From GlobeNewswire: 2025-06-13 09:20:00

The Biological Safety Cabinet Market was valued at USD 224.85 million in 2023 and is projected to reach USD 404.98 million by 2032, growing at a CAGR of 6.76%. The U.S. market alone is expected to reach USD 114.20 million by 2032, driven by pharmaceutical and biotechnology sectors. The Class II segment dominates the market with 58.3% share, catering to biosafety levels 2 and 3 containment needs. Pharmaceutical and biopharmaceutical companies hold the largest market share at 42.8%, emphasizing the importance of biosafety in drug discovery and production. North America leads the market with rigorous safety standards and significant research funding, while Asia-Pacific is poised for rapid growth due to increased investment in healthcare infrastructure and rising biosafety awareness.



Read more at GlobeNewswire: Biological Safety Cabinet Market Set to Reach USD 404.98